A research team says it has developed a new type of stem cell--capable of developing into any kind of tissue--that could pave the way to new cell lines that could be made more efficiently, opening up its potential in R&D.
Researchers have hit on a new approach to creating functional melanocytes, the body's pigment-producing cells. And their work could spur a fresh approach to screening and developing new drugs for melanoma as well as producing new cell-based therapies for a variety of skin diseases.
Working around the notion that cancer-causing mutations on receptors found in bone marrow stem cells could explain why some patients grow resistant to currently used leukemia drugs, researchers at the Indiana University School of Medicine say they've been successful in testing a new approach to fighting the disease.
Using human pluripotent stem cells, scientists at Cincinnati Children's Hospital Medical Center have grown functional 3D human stomach tissue for the first time.
Scientists have figured out a way to harness stem cells so that they can be used to produce and emit toxins capable of killing brain tumors.
Researchers have grown human intestinal tissue from pluripotent stem cells and transplanted the living tissue into mice. These so-called organoids could provide a more accurate model for testing drugs designed to work on the intestines as well as help generate intestinal tissue for new treatments.
Scientists from Harvard University have developed a technique that coaxes embryonic stem cells into fully functioning human insulin-producing beta cells, possibly paving the way for less invasive and more permanent treatment options for Type 1 diabetes.
Scientists at the New York University Langone Medical Center have developed a new technique that uses three familiar compounds, including vitamin C, to generate adult stem cells into pluripotent stem cells at a dramatically more efficient rate--more than 20-fold compared to the current method.
European and Japanese scientists have figured out how to "reset" human pluripotent stem cells, turning back the clock on cells so that they revert to their original state at the height of their development potential.
Researchers have found a molecular process that prompts blood stem cells to self-renew while retaining their stem cell-like properties, a discovery that could allow scientists to regrow enough cells in a lab for transplantation.